OTTAWA, Feb 23 (Reuters) - Canada's Competition Bureau onMonday approved a deal between GlaxoSmithKline PLC andNovartis AG, noting in a statement that U.S.authorities had already said the transaction could go ahead.
The companies agreed last April to the transaction thatincludes GSK buying Novartis' vaccines business, Novartispurchasing GSK's cancer drugs, and the two groups tying up inconsumer healthcare. (Reporting by David Ljunggren)